Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-02-21 Purchase |
2023-02-21 8:05 pm |
Context Therapeutics Inc. | CNTX | Lehr Martin A. Chief Executive Officer |
5,823 | $0.8415 | $4,900 | 979,891 (Indirect Direct) |
View |
| 2023-02-13 Purchase |
2023-02-13 4:03 pm |
Context Therapeutics Inc. | CNTX | Lehr Martin A. Chief Executive Officer |
5,606 | $0.8742 | $4,901 | 974,068 (Indirect Direct) |
View |
| 2023-02-06 Purchase |
2023-02-06 4:03 pm |
Context Therapeutics Inc. | CNTX | Lehr Martin A. Chief Executive Officer |
5,040 | $0.9723 | $4,900 | 968,462 (Indirect Direct) |
View |
| 2023-01-30 Purchase |
2023-01-30 4:03 pm |
Context Therapeutics Inc. | CNTX | Lehr Martin A. Chief Executive Officer |
7,027 | $0.6974 | $4,901 | 963,422 (Indirect Direct) |
View |
| 2023-01-23 Purchase |
2023-01-23 5:03 pm |
Context Therapeutics Inc. | CNTX | Lehr Martin A. Chief Executive Officer |
6,839 | $0.7166 | $4,901 | 956,395 (Indirect Direct) |
View |
| 2023-01-17 Purchase |
2023-01-18 4:04 pm |
Context Therapeutics Inc. | CNTX | Lehr Martin A. Chief Executive Officer |
6,783 | $0.7364 | $4,995 | 949,556 (Indirect Direct) |
View |
| 2022-12-16 Purchase |
2022-12-19 4:11 pm |
Context Therapeutics Inc. | CNTX | Lehr Martin A. Chief Executive Officer |
20,000 | $0.7398 | $14,796 | 942,773 (Indirect Direct) |
View |
| 2022-08-19 Purchase |
2022-08-22 4:04 pm |
Context Therapeutics Inc. | CNTX | Lehr Martin A. Chief Executive Officer |
13,000 | $1.8511 | $24,064 | 922,773 (Indirect Direct) |
View |
| 2021-12-16 Purchase |
2021-12-20 4:02 pm |
Context Therapeutics Inc. | CNTX | Lehr Martin A. Chief Executive Officer |
13,000 | $3.2192 | $41,850 | 909,773 (Indirect Direct) |
View |
| 2021-10-22 Purchase(A) |
2021-12-17 4:18 pm |
Context Therapeutics Inc. | CNTX | Lehr Martin A. Chief Executive Officer |
10,000 | $5 | $50,000 | 896,781 (Indirect Direct) |
View |
| 2021-10-22 Purchase |
2021-10-25 5:30 pm |
Context Therapeutics Inc. | CNTX | Lehr Martin A. Chief Executive Officer |
10,000 | $5 | $50,000 | 949,461 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-13 Option Award |
2025-02-14 4:06 pm |
N/A 2035-02-12 |
Context Therapeutics Inc. | CNTX | Lehr Martin A. Chief Executive Officer |
802,700 | $0 | 802,700 (Direct) |
View |
| 2024-03-21 Option Award |
2024-03-22 08:01 am |
N/A 2034-03-20 |
Context Therapeutics Inc. | CNTX | Lehr Martin A. Chief Executive Officer |
291,402 | $0 | 291,402 (Direct) |
View |
| 2023-02-13 Option Award |
2023-02-14 5:04 pm |
N/A 2033-02-12 |
Context Therapeutics Inc. | CNTX | Lehr Martin A. Chief Executive Officer |
287,544 | $0 | 287,544 (Direct) |
View |
| 2022-02-25 Option Award |
2022-02-25 4:38 pm |
N/A 2032-02-24 |
Context Therapeutics Inc. | CNTX | Lehr Martin A. Chief Executive Officer |
254,300 | $0 | 254,300 (Direct) |
View |
| 2021-10-22 Exercise(A) |
2021-12-17 4:18 pm |
2020-12-20 2030-12-20 |
Context Therapeutics Inc. | CNTX | Lehr Martin A. Chief Executive Officer |
52,680 | $0 | 896,781 (Indirect) |
View |
| 2021-10-22 Conversion(A) |
2021-12-17 4:18 pm |
N/A N/A |
Context Therapeutics Inc. | CNTX | Lehr Martin A. Chief Executive Officer |
797,190 | $0 | 896,781 (Indirect) |
View |
| 2021-10-22 Exercise(A) |
2021-12-17 4:18 pm |
N/A N/A |
Context Therapeutics Inc. | CNTX | Lehr Martin A. Chief Executive Officer |
52,680 | $7.14 | 896,781 (Indirect) |
View |
| 2021-10-22 Exercise |
2021-10-25 5:30 pm |
2020-12-20 2030-12-20 |
Context Therapeutics Inc. | CNTX | Lehr Martin A. Chief Executive Officer |
52,680 | $0 | 949,461 (Indirect) |
View |
| 2021-10-22 Conversion |
2021-10-25 5:30 pm |
N/A N/A |
Context Therapeutics Inc. | CNTX | Lehr Martin A. Chief Executive Officer |
797,198 | $0 | 949,461 (Indirect) |
View |
| 2021-10-22 Exercise |
2021-10-25 5:30 pm |
N/A N/A |
Context Therapeutics Inc. | CNTX | Lehr Martin A. Chief Executive Officer |
52,680 | $7.14 | 949,461 (Indirect) |
View |
Ownership |
2021-10-19 6:11 pm |
N/A N/A |
Context Therapeutics Inc. | CNTX | Lehr Martin A. Chief Executive Officer |
0 | $0 | 1,220,815 (Direct) |
View |